Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease

被引：1
|
作者：
Vieira, Sophia R. L. [1 ]
Mezabrovschi, Roxana [1 ]
Toffoli, Marco [1 ]
Del Pozo, Sara Lucas [1 ]
Menozzi, Elisa [1 ]
Mullin, Stephen [1 ,2 ]
Yalkic, Selen [1 ]
Limbachiya, Naomi [1 ]
Koletsi, Sofia [1 ,3 ]
Loefflad, Nadine [1 ]
Lopez, Grisel J. [4 ]
Gan-Or, Ziv [5 ,6 ]
Alcalay, Roy N. [7 ,8 ]
Sidransky, Ellen [3 ,4 ]
Schapira, Anthony H. V. [1 ,3 ]
机构：
[1] Univ Coll London Queen Sq, Dept Clin & Movement Neurosci, Inst Neurol, London, England
[2] Univ Plymouth, Fac Hlth, Plymouth, England
[3] Aligning Sci Parkinsons Collaborat Res Network, Chevy Chase, MD USA
[4] Natl Human Genome Res Inst, Med Genet Branch, NIH, Bethesda, MD USA
[5] McGill Univ, Neuro Montreal Neurol Inst Hosp, Dept Neurol & Neurosurg, Montreal, PQ, Canada
[6] McGill Univ, Dept Human Genet, Montreal, PQ, Canada
[7] Columbia Univ, Irving Med Ctr, New York, NY USA
[8] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Tel Aviv Sch Med, Tel Aviv, Israel
来源：
MOVEMENT DISORDERS | 2024年 / 39卷 / 12期
关键词：
GBA1; Parkinson's; counseling; neurodegeneration; risk; GLUCOCEREBROSIDASE MUTATIONS; GAUCHER-DISEASE; ASSOCIATION; RISK; MULTICENTER; PROGRESSION; DEMENTIA; POLYMORPHISM; SURVIVAL; MOTOR;
D O I：
10.1002/mds.30006
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Glucocerebrosidase (GBA1) variants constitute numerically the most common known genetic risk factor for Parkinson's disease (PD) and are distributed worldwide. Access to GBA1 genotyping varies across the world and even regionally within countries. Guidelines for GBA1 variant counseling are evolving. We review the current knowledge of the link between GBA1 and PD, and discuss the practicalities of GBA1 testing. Lastly, we provide a consensus for an approach to counseling people with GBA1 variants, notably the communication of PD risk. (c) 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
引用
收藏
页码：2144 / 2154
页数：11
相关论文
共 50 条
  • [21] Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants
    Pal, Gian D.
    Corcos, Daniel M.
    Metman, Leo Verhagen
    Israel, Zvi
    Bergman, Hagai
    Arkadir, David
    MOVEMENT DISORDERS, 2023, 38 (12) : 2155 - 2162
  • [22] Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson's disease
    Stoker, Thomas B.
    Camacho, Marta
    Winder-Rhodes, Sophie
    Liu, Ganqiang
    Scherzer, Clemens R.
    Foltynie, Thomas
    Evans, Jonathan
    Breen, David P.
    Barker, Roger
    Williams-Gray, Caroline H.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2020, 91 (07): : 695 - 702
  • [23] Classification and genotype-phenotype relationships of GBA1 variants and Parkinson's disease: MDSGene Systematic Review
    Usnich, T.
    Rossi, M.
    Schaake, S.
    Schell, N.
    Boehm, J.
    Steffen, N.
    Krueger, C.
    Alcalay, R.
    Lohmann, K.
    Klein, C.
    MOVEMENT DISORDERS, 2023, 38 : S492 - S492
  • [24] Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease
    Surface, Matthew
    Balwani, Manisha
    Waters, Cheryl
    Haimovich, Alexander
    Gan-Or, Ziv
    Marder, Karen S.
    Hsieh, Tammy
    Song, Linxia
    Padmanabhan, Shalini
    Hsieh, Frank
    Merchant, Kalpana M.
    Alcalay, Roy N.
    MOVEMENT DISORDERS, 2022, 37 (02) : 416 - 421
  • [25] GBA1 in Parkinson's disease: variant detection and pathogenicity scoring matters
    Gabbert, Carolin
    Schaake, Susen
    Lueth, Theresa
    Much, Christoph
    Klein, Christine
    Aasly, Jan O.
    Farrer, Matthew J.
    Trinh, Joanne
    BMC GENOMICS, 2023, 24 (01)
  • [26] Male sex accelerates cognitive decline in GBA1 Parkinson's disease
    Caminiti, Silvia Paola
    Avenali, Micol
    Galli, Alice
    Malito, Rachele
    Cuconato, Giada
    Galandra, Caterina
    Calabrese, Rosaria
    Pilotto, Andrea
    Padovani, Alessandro
    Blandini, Fabio
    Perani, Daniela
    Tassorelli, Cristina
    Valente, Enza Maria
    NPJ PARKINSONS DISEASE, 2025, 11 (01)
  • [27] GBA1 in Parkinson’s disease: variant detection and pathogenicity scoring matters
    Carolin Gabbert
    Susen Schaake
    Theresa Lüth
    Christoph Much
    Christine Klein
    Jan O. Aasly
    Matthew J. Farrer
    Joanne Trinh
    BMC Genomics, 24
  • [28] The Role of Cholesterol in α-Synuclein and Lewy Body Pathology in GBA1 Parkinson's Disease
    Garcia-Sanz, Patricia
    M.F.G. Aerts, Johannes
    Moratalla, Rosario
    MOVEMENT DISORDERS, 2021, 36 (05) : 1070 - 1085
  • [29] Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?
    Kopytova, Alena E.
    Usenko, Tatiana S.
    Baydakova, Galina V.
    Nikolaev, Mikhail A.
    Senkevich, Konstantin A.
    Izyumchenko, Artem D.
    Tyurin, Alexandr A.
    Miliukhina, Irina V.
    Emelyanov, Anton K.
    Zakharova, Ekaterina Y.
    Pchelina, Sofya N.
    MOVEMENT DISORDERS, 2022, 37 (08) : 1779 - 1781
  • [30] Investigating the pathogenesis of GBA1-associated Parkinson's disease (PD) using GBA1 isogenic iPSC lines
    Chen, Y.
    Chen, C.
    Ma, C.
    Lichtenberg, J.
    Hertz, E.
    Jong, T.
    Sam, R.
    Li, Y.
    Vrisjen, S.
    Vangheluwe, P.
    Blauwendraat, C.
    Sidransky, E.
    MOVEMENT DISORDERS, 2024, 39 : S414 - S414
12345